Details der Publikation - Frontiers in health policy research vol. 7

Frontiers in health policy research vol. 7 / edited by David M. Cutler and Alan M. Garber

Introduction /David M. Cutler and Alan M. Garber --Reference pricing of pharmaceuticals for medicare: evidence from Germany, the Netherlands, and New Zealand /Patricia M. Danzon and Jonathan D. Ketcham --Adverse selection and the challenges to stand-alone prescription drug insurance /Mark V. Pauly and Yuhui Zeng --Disability forecasts and future medicare costs /Jayanta Bhattacharya [and others] --Benefit plan design and prescription drug utilization among asthmatics: do patient copayments matter? /William H. Crown [and others] --An economic analysis of health plan conversions: are they in the public interest? /Nancy Dean Beaulieu..

This series from the NBER presents new research by leading economists on current health care policy issues. The papers in this seventh volume, originally presented at the annual Frontiers in Health Policy Research conference held in Washington D.C. in the summer of 2003, reflect the economic challenges faced by policymakers and health care professionals in an age of budget deficits. Topics discussed include prescription drug benefits as a stand-alone component of Medicare, disability rates and Medicare costs, and conversion to for-profit health plans.

Medienart:	E-Book

Erscheinungsjahr:	2004
Erschienen:	Cambridge, Mass: MIT Press ; 2004

Reproduktion:	Online-Ausg.

Sprache:	Englisch

Beteiligte Personen:	Cutler, David M., 1965- [Sonstige Person] Garber, Alan M. [Sonstige Person]
Congresses:	Frontiers in Health Policy Research Conference ; 7th ; Washington, D.C. ; 2003

Links:	search.ebscohost.com [lizenzpflichtig] Inhaltsverzeichnis

ISBN:	978-0-262-27105-9 0-262-27105-2

Themen:	BUSINESS & ECONOMICS ; Insurance ; Health Conference papers and proceedings Drugs Drugs ; Prices Electronic books Health insurance Insurance Insurance ; Plans Konferenzschrift Medical economics Medical policy Medical policy ; Economic aspects Medicare Medicare ; Costs Nonprofit organizations Pharmaceutical services insurance Privatization United States

Anmerkungen:	"National Bureau of Economic Research. - These papers were presented at the seventh annual Frontiers in Health Policy Research meeting held in Washington, D.C., in the summer of 2003. - Includes bibliographical references. - Description based on print version record Includes bibliographical references These papers were presented at the seventh annual Frontiers in Health Policy Research meeting held in Washington, D.C., in the summer of 2003

Umfang:	Online Ressource (1 v.) ; ill.

Förderinstitution / Projekttitel:

PPN (Katalog-ID):	801250250

Internformat


LEADER	01000cam a22002652 4500
001	801250250
003	DE-627
005	20230428160748.0
007	cr uuu---uuuuu
008	141209s2004 xxu\|\|\|\|\|o 00\| \|\|eng c
020			\|a 9780262271059 \|c : electronic bk. \|9 978-0-262-27105-9
020			\|a 0262271052 \|c electronic bk. \|9 0-262-27105-2
035			\|a (DE-627)801250250
035			\|a (DE-576)422337463
035			\|a (DE-599)GBV801250250
035			\|a (OCoLC)57572610
035			\|a (OCoLC)57572610
035			\|a (EbpS)125994
035			\|a (EBP)016117875
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
044			\|c XD-US
050		0	\|a HG9396
072		7	\|a BUS033040 \|2 bisacsh
072		7	\|a BUS 033040 \|2 bisacsh
110	2		\|a Frontiers in Health Policy Research Conference \|g (7th, 2003, Washington, D.C.) \|4 aut
245	1	0	\|a Frontiers in health policy research \|p vol. 7 \|c edited by David M. Cutler and Alan M. Garber
264		1	\|a Cambridge, Mass \|b MIT Press \|c 2004
300			\|a Online Ressource (1 v.) \|b ill.
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a "National Bureau of Economic Research. - These papers were presented at the seventh annual Frontiers in Health Policy Research meeting held in Washington, D.C., in the summer of 2003. - Includes bibliographical references. - Description based on print version record
500			\|a Includes bibliographical references
500			\|a These papers were presented at the seventh annual Frontiers in Health Policy Research meeting held in Washington, D.C., in the summer of 2003
505	8	0	\|t Introduction \|r David M. Cutler and Alan M. Garber
505	8	0	\|t Reference pricing of pharmaceuticals for medicare: evidence from Germany, the Netherlands, and New Zealand \|r Patricia M. Danzon and Jonathan D. Ketcham
505	8	0	\|t Adverse selection and the challenges to stand-alone prescription drug insurance \|r Mark V. Pauly and Yuhui Zeng
505	8	0	\|t Disability forecasts and future medicare costs \|r Jayanta Bhattacharya ... [et al.]
505	8	0	\|t Benefit plan design and prescription drug utilization among asthmatics: do patient copayments matter? \|r William H. Crown ... [et al.]
505	8	0	\|t An economic analysis of health plan conversions: are they in the public interest? \|r Nancy Dean Beaulieu.
520			\|a Introduction /David M. Cutler and Alan M. Garber --Reference pricing of pharmaceuticals for medicare: evidence from Germany, the Netherlands, and New Zealand /Patricia M. Danzon and Jonathan D. Ketcham --Adverse selection and the challenges to stand-alone prescription drug insurance /Mark V. Pauly and Yuhui Zeng --Disability forecasts and future medicare costs /Jayanta Bhattacharya [and others] --Benefit plan design and prescription drug utilization among asthmatics: do patient copayments matter? /William H. Crown [and others] --An economic analysis of health plan conversions: are they in the public interest? /Nancy Dean Beaulieu.
520			\|a This series from the NBER presents new research by leading economists on current health care policy issues. The papers in this seventh volume, originally presented at the annual Frontiers in Health Policy Research conference held in Washington D.C. in the summer of 2003, reflect the economic challenges faced by policymakers and health care professionals in an age of budget deficits. Topics discussed include prescription drug benefits as a stand-alone component of Medicare, disability rates and Medicare costs, and conversion to for-profit health plans
533			\|a Online-Ausg.
650		0	\|a Health insurance \|x Congresses \|x United States
650		0	\|a Drugs \|x Congresses \|x Prices \|x United States
650		0	\|a Pharmaceutical services insurance \|x Congresses \|x United States
650		0	\|a Medicare \|x Congresses \|x Costs \|x United States
650		0	\|a Nonprofit organizations \|x Congresses \|x United States
650		0	\|a Privatization \|x Congresses \|x United States
650		0	\|a Insurance \|x Congresses \|x Plans \|x United States
650		0	\|a Medical policy \|x Congresses \|x United States
650		0	\|a Medical policy \|x Congresses \|x Economic aspects \|x United States
650		0	\|a Medical economics \|x Congresses \|x United States \|x United States
650		0	\|a Pharmaceutical services insurance \|z United States \|v Congresses
650		0	\|a Medicare \|z United States \|x Costs \|v Congresses
650		0	\|a Nonprofit organizations \|z United States \|v Congresses
650		0	\|a Privatization \|z United States \|v Congresses
650		0	\|a Insurance \|z United States \|x Plans \|v Congresses
650		0	\|a Medical policy \|z United States \|v Congresses
650		0	\|a Medical policy \|x Economic aspects \|z United States \|v Congresses
650		0	\|a Medical economics \|z United States \|v Congresses
650		0	\|a Drugs \|x Prices \|z United States \|v Congresses
650		0	\|a Health insurance \|z United States \|v Congresses
650		0	\|a Insurance \|z United States \|x Plans \|v Congresses
650		0	\|a Medical policy \|z United States \|v Congresses
650		0	\|a Medical policy \|x Economic aspects \|z United States \|v Congresses
650		0	\|a Medical economics \|z United States \|v Congresses
650		0	\|a Nonprofit organizations \|z United States \|v Congresses
650		0	\|a Drugs \|x Prices \|z United States \|v Congresses
650		0	\|a Pharmaceutical services insurance \|z United States \|v Congresses
650		0	\|a Privatization \|z United States \|v Congresses
650		0	\|a Health insurance \|z United States \|v Congresses
650		0	\|a Medicare \|z United States \|x Costs \|v Congresses
650		4	\|a Insurance ; Plans
650		4	\|a Medical economics
650		4	\|a Medical policy
650		4	\|a Medical policy ; Economic aspects
650		4	\|a Medicare ; Costs
650		4	\|a Nonprofit organizations
650		4	\|a Pharmaceutical services insurance
650		4	\|a Privatization
650		4	\|a Health insurance
650		4	\|a Conference papers and proceedings
650		4	\|a BUSINESS & ECONOMICS ; Insurance ; Health
650		4	\|a Drugs ; Prices
651		4	\|a United States
655		4	\|a Electronic books \|x Conference proceedings
655		7	\|a Konferenzschrift \|0 (DE-588)1071861417 \|0 (DE-627)826484824 \|0 (DE-576)433375485 \|2 gnd-content
700	1		\|a Cutler, David M. \|d 1965- \|0 (DE-588)124160662 \|0 (DE-627)085677280 \|0 (DE-576)294046992 \|4 oth
700	1		\|a Garber, Alan M. \|0 (DE-588)129516503 \|0 (DE-627)471005622 \|0 (DE-576)297700596 \|4 oth
710	2		\|a National Bureau of Economic Research \|4 oth
711	2	9	\|a Frontiers in Health Policy Research Conference \|n 7th \|c Washington, D.C. \|d 2003
776	1		\|z 0262033259
776	1		\|z 0262532662
776	0	8	\|i Print version \|a Frontiers in health policy research. vol. 7
856	4	0	\|u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=125994 \|m X:EBSCO \|x Aggregator \|z lizenzpflichtig
856	4	2	\|u http://www.gbv.de/dms/bowker/toc/9780262033251.pdf \|m V:DE-601 \|m X:Bowker \|q pdf/application \|v 2017-02-24 \|x Verlag \|y Inhaltsverzeichnis \|3 Inhaltsverzeichnis
912			\|a ZDB-4-EBA
912			\|a ZDB-4-NLEBK
912			\|a GBV_ILN_2001
912			\|a ISIL_DE-21
912			\|a SYSFLAG_1
912			\|a GBV_KXP
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_2005
912			\|a ISIL_DE-291
912			\|a GBV_ILN_2111
912			\|a ISIL_DE-944
912			\|a GBV_ILN_2113
912			\|a ISIL_DE-753
935			\|i Blocktest
951			\|a BO
953			\|2 045F \|a 368.38200973
980			\|2 2001 \|1 01 \|x DE-21 \|b 3389599940 \|c 00 \|f --%%-- \|d --%%-- \|e n \|j --%%-- \|y l01 \|z 01-04-16
980			\|2 2005 \|1 01 \|x DE-291 \|b 338960006X \|c 00 \|f --%%-- \|d --%%-- \|e n \|j --%%-- \|y l01 \|z 05-02-05
980			\|2 2111 \|1 01 \|x DE-944 \|b 3775914900 \|c 00 \|f --%%-- \|d E-Book EBSCO \|e --%%-- \|j n \|k Elektronischer Volltext - Campuslizenz \|y l01 \|z 10-10-20
980			\|2 2113 \|1 01 \|x DE-753 \|b 3775914919 \|c 00 \|f --%%-- \|d E-Book Ebsco \|e --%%-- \|j n \|k Elektronischer Volltext - Campuslizenz \|y l01 \|z 10-10-20
981			\|2 2001 \|1 01 \|x DE-21 \|r https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=125994
981			\|2 2005 \|1 01 \|x DE-291 \|r https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=125994
981			\|2 2111 \|1 01 \|x DE-944 \|r https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=125994
981			\|2 2113 \|1 01 \|x DE-753 \|r https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=125994
982			\|2 2001 \|1 01 \|x DE-21 \|8 00 \|s s \|a eBook-EBSCO-eBook-Academic-Collection
983			\|2 2111 \|1 01 \|x DE-944 \|8 00 \|0 (DE-627)1353370437 \|a e-Book

Frontiers in health policy research vol. 7 / edited by David M. Cutler and Alan M. Garber

Zugang & Verfügbarkeit

Zugehörige Publikationen/Bände